
DISCO Pharmaceuticals gets $40M upfront from AbbVie and could earn up to $2.5B in milestones to develop AND-gated bispecifics for solid tumors.
2013 Oncology Practice Roundtable
almost 14 years ago
Country Report: Australiaalmost 14 years ago
Turkey: A Promise Restored?almost 14 years ago
NHTSA Addresses "Drugged Driving"almost 14 years ago
Fortuity and the First Amendmentalmost 14 years ago
PE, February 2013 Cover Imagealmost 14 years ago
Oncology: Pathways to Progress





